The treatment of leishmania with antimony potassium tartrate started in 1913. The origins of genus "Leishmania" itself are unclear. Leishmaniasis is a disease caused by protozoan parasites of the genus "Leishmania". Leishmaniasis is a disease caused by parasites of the "Leishmania" type. The protozoan parasite itself is a species of the genus "Leishmania". Others include "Cryptobia" and the parasitic "Leishmania". The CMI that kills "Leishmania" also produces inflammation. CXCL10, implicating CXCL10 in host defense mechanisms of certain intracellular pathogens like "Leishmania". The genus is presently divided into 4 subgenera&colon; "Leishmania", "Sauroleishmania", "Mundinia" and "Viannia". This process is known as anterior station development, which is unique in "Leishmania". The best-studied treatments for ACML caused by two Leishmania species are listed below. "L. herreri" belongs to the genus "Endotypanum" rather than to "Leishmania". "Endotrypanum" is closely related to "Leishmania". Infections in humans are caused by more than 20 species of "Leishmania". "Leishmania" currently affects 6 million people in 98 countries.